1. Bárcena R, Moreno A, Rodríguez-Gandía MA, Albillos A, Arocena C, Blesa C, et al.
Hospital Ramón y Cajal Liver Transplant Group Safety andanti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.
J Hepatol. 2013 Mar;58(3):421-6
2. Bartoletti M, Cervera C, Hoyo I, Linares L, Sanclemente G, Bosch J, Marco F, Cofán F, Ricart MJ, Navasa M, Moreno A.
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation.
Mycoses. 2013 Mar;56(2):162-167
3. Berastegui C, Monforte V, Bravo C, Sole J, Gavalda J, Tenório L, Villar A, Rochera MI, Canela M, Morell F, Roman A.
[Lung transplantation in pulmonary fibrosis and other interstitial lung diseases.]
Med Clin (Barc). 2013 Sep 9. [Epub ahead of print]
4. Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, Cruzado JM, Carratalà J.
Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
TRANSPLANTATION 2013; 96: 843-9.
5. Cantisan S, Lara R, Montejo M, et al.
Pretrasplant Interferon-? Secretion by CMV-Specific CD8+TCells Inform the Risk of CMV Replication After Trasplantation.
Am J Trasplant 2013;13:738-745.
6. Cantisán S, Torre-Cisneros J, Lara R, Zarraga S, Montejo M, Solana R.
Impact of Cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation.
J Gerontol A Biol Sci Med Sci. 2013; 68(1): 1-5.
7. Clari MA, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, BenMarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D.
Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.
Diagnostic Microbiology and Infectious Disease. 2013 Feb;75(2):207-9.
8. Coll, E; Torre-Cisneros, J; Calvo, R; Garrido, G; Matesanz, R.
Incidence of Tuberculosis in Deceased-Organ Donors and Transmission Risk to Recipients in Spain.
Transplantation. 2013 Jul 27; 96(2):205-10
9. Cordero E; de la Torre-Cisneros J; Moreno A; Pérez-Romero P; Riera M.
The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients.
Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:38-42
10. Cuervo G, Garcia-Vidal C, Nucci M, Puchades F, Fernández-Ruiz M, Mykietiuk A, Manzur A, Gudiol C, Peman J, Viasus D, Ayats J, Carratalà J.
Effect of statin use on outcomes of adults with candidemia.
PLoS ONE 2013; 8 :e77317.
11. Falantes JF, Calderón C, Márquez-Malaver FJ, Aguilar-Guisado M, Martín-Peña A, Martino ML, Montero I, González J, Parody R, Pérez-Simón JA, Espigado I.
Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. Candidates for primary antifungal prophylaxis.
Clinical Lymphoma, Myeloma & Leucemia, in press 2013.
12. Constantino Fernández-Rivera, Cristina Varela, E. Sabater-Cabrera, Elena Ruiz-Beato, Julián Torre-Cisneros, Luis Guirado Perich.
Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo.
Pharmacoeconomics SRA. 2013; 10, (Issue 1); 15-25.
13. Fernandez-Ruiz M, Lopez-Medrano F, Andres A, et al.
Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients.
Transpl Infect Dis 2013 Dec;15(6):600-11.
14. Fernandez-Ruiz M, Lopez-Medrano F, Varela-Pena P, et al.
Hypocomplementemia in kidney transplant recipients: impact on the risk of infectious complications.
Am J Transplant 2013 Mar;13(3):685-94.
15. Fernandez-Ruiz M, San-Juan R, Aguado JM.
Epstein-Barr virus DNAemia and infectious complications after preemptive rituximab treatment.
Transplantation 2013 Feb 15;95(3):e13.
16. Garcia-Reyne A, Lumbreras C, Fernandez I, et al.
Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
Transpl Infect Dis 2013 Aug;15(4):405-15.
17. Garcia-Vidal C, Viasus D, Carratalà J.
Pathogenesis of invasive fungal infections.
Current Opinion Infect Dis 2013; 26: 270-6 I
18. Gayoso I, Cantisán S, Cerrato S, Sánchez-García j, Martín C, Solana R, Torres-Gómez A, Torre-Cisneros J.
Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation.
Clin Dev Immunol. 2013; 2013:347213.
19. Gavaldà J, Cabral E, Pérez-Romero P, Len O, Aydillo T, Campins M, Quintero J, Peghin M, Nieto J, Charco R, Pahissa A, Cordero E;
Spanish Network for the Research in Infectious Diseases (REIPI). Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.
Pediatr Transplant. 2013 Jun;17(4):403-6.
20. González-Padilla M, Castón JJ, Vidal E, Arizón JM, Segura C, Montejo M, Rivero A, Torre-Cisneros J.
Epidemiology and clinical impact of infection in patients awaiting heart transplantation.
Int J Infect Dis. 2013 Sep;17(9):e681-5.
21. Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?.
Int J Cardiol. 2014; 171:15-23
22. Gracia-Ahufinger I; Gutiérrez-Aroca J; Cordero E; Vidal E; Cantisán S; del Castillo D; Martín-Gandul C; Rivero A; Torre-Cisneros J.
Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.
Transplantation. 2013 Apr 27;95(8):1015-20.
23. Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, Domingo-Domenech E, Jiménez L, Carratalà J.
Changing etiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Clin Microbiol Infect 2013; 19: 474-9.
24. Gudiol C, Camoez M, Domínguez MA, Garcia-Vidal C, Bodro M, Ardanuy C, Obed M, Arnan M, Antonio M, Carratalà J.
Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.
PLoS ONE 2013; 8: e74734.
25. Herrero-Martinez JM, Lumbreras C, Manrique A, et al.
Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation.
Clin Microbiol Infect 2013 Dec;19(12):1132-9.
26. Jaramillo N, Segovia J, Gómez-Bueno M, García-Cosío D, Castedo E, Serrano S, Burgos R, García Montero C, Ugarte J, Martínez Cabeza P, Alonso-Pulpón L.
Characteristics of Patients With Survival Longer Than 20 Years Following Heart Transplantation.
Rev Esp Cardiol. 2013; 66:797-802
27. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L.
Humar A Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.; Transplantation Society International CMV Consensus Group.
Transplantation. 2013 Aug 27;96(4):333-60.
28. Ledesma J, Bouza E, González-Nicolás MA, de Viedma DG, Rodríguez-Sánchez B, Muñoz P.
BK polyomavirus genotyping at inter- and intra-patient level in Spain.
J Med Virol. 2013 Aug;85(8):1402-8.
29. López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MA, Pérez-Romero P, Sabé N, Gómez-Bravo MA, Delgado JF, Cabral E, Carratalá J.
Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). Executive summary. Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
Enferm Infecc Microbiol Clin. 2013 Oct;31(8):528-34.
30. López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MA, Pérez-Romero P, Sabé N, Gómez-Bravo MA, Delgado JF, Cabral E, Carratalá J.
Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
Enferm Infecc Microbiol Clin. 2013 Oct;31(8):526.e1-526.e20.
31. Martín-Gandul C*, Pérez-Romero P*, Sánchez M, Bernal G, Suárez G, Sobrino M, Merino L, Cisneros JM, Cordero E.
The Spanish Network for Research in Infectious Diseases (REIPI). Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.
J Clin Virol. 2013 Jan;56(1):13-18. *Both author contributed equally to this work.
32. Martín-Peña A, Aguilar-Guisado M, Cisneros JM.
Does the current treatment of invasive fungal infection need to be reviewed?.
Enfermedades Infecciosas y Microbiología Clínica, 2013 (en prensa).
33. Martín-Peña A, Gil-Navarro MV, Aguilar-Guisado M, Espigado I, de Pipaón MR, Falantes J, Pachón J, Cisneros JM.
Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.
Antimicrob Agents Chemother. 2013;57(10):4664-72.
34. Monforte V, López-Sánchez A, Zurbano F, Ussetti P, Solé A, Casals C, Cifrian J, de Pablos A, Bravo C, Román A.
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
J Heart Lung Transplant. 2013 Mar;32(3):313-9
35. Munoz P, Valerio M, Palomo J, et al.
Targeted antifungal prophylaxis in heart transplant recipients.
Transplantation 2013 Oct 15;96(7):664-9.
36. Muñoz P, Cerón I, Valerio M, Palomo J, Villa A, Eworo A, Fernández-Yáñez J, Guinea J, Bouza E.
Invasive Aspergillosis Among Heart Transplant Recipients: A 24-Year Perspective II.
Journal of Heart and Lung trasplantation (in press).
37. San-Juan R, De Dios B, Garcia-Reyne A, et al.
Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant.
J Clin Virol 2013 Apr;56(4):316-22.
38. San-Juan R, De Dios B, Navarro D, et al.
Epstein-Barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients.
Transplantation 2013 Mar 15;95(5):688-93.
39. Sousa D, Justo I, Domínguez A, Manzur A, Izquierdo C, Ruiz L, Nebot M, Bayas JM, Celorrio JM, Varona W, Llinares P, Miguez E, Sánchez E, Carratalà J.
Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome.
Clin Microbiol Infect 2013; 19: 187-92
40. Sun, Hsin-Yun; Munoz, Patricia; Torre-Cisneros, Julian; Aguado, Jose M.; Lattes, Roberta; Montejo, Miguel; Garcia-Reyne, Ana; Bouza Emilio; Valerio, Maricela; Lara, Rosario; John, George T.; Bruno, Didier; Singh, Nina.
Mycobacterium Tuberculosis—Associated Immune Reconstitution Syndrome in Solid-Organ Transplant Recipient.
Trasplantation 2013;95 (9) : 1173-81.
41. Zuckermann A, Wang SS, Epailly E, Barten MJ, Sigurdardottir V, Segovia J, Varnous S, Turazza FM, Potena L, Lehmkuhl HB.
Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?.
Transplant Rev (Orlando). 2013; 27:76-84.